Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
We describe a novel therapeutic approach for cirrhosis using mesenchymal stem cells (MSCs) and colony-stimulating factor-1-induced bone marrow-derived macrophages (id-BMMs) and analyze the mechanisms underlying fibrosis improvement and regeneration. Mouse MSCs and id-BMMs were cultured from mouse bone marrow and their interactions analyzed in vitro. MSCs, id-BMMs, and a combination therapy using MSCs and id-BMMs were administered to mice with CCl4-induced cirrhosis. Fibrosis regression, liver regeneration, and liver-migrating host cells were evaluated. Administered cell behavior was also tracked by intravital imaging. In coculture, MSCs induced switching of id-BMMs toward the M2 phenotype with high phagocytic activity. In vivo, the combination therapy reduced liver fibrosis (associated with increased matrix metalloproteinases expression), increased hepatocyte proliferation (associated with increased hepatocyte growth factor, vascular endothelial growth factor, and oncostatin M in the liver), and reduced blood levels of liver enzymes, more effectively than MSCs or id-BMMs monotherapy. Intravital imaging showed that after combination cell administration, a large number of id-BMMs, which phagocytosed hepatocyte debris and were retained in the liver for more than 7 days, along with a few MSCs, the majority of which were trapped in the lung, migrated to the fibrotic area in the liver. Host macrophages and neutrophils infiltrated after combination therapy and contributed to liver fibrosis regression and promoted regeneration along with administered cells. Indirect effector MSCs and direct effector id-BMMs synergistically improved cirrhosis along with host cells in mice. These studies pave the way for new treatments for cirrhosis. Stem Cells Translational Medicine 2019;8:271&284
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Analysis of mRNA expression changes for factors related to fibrosis and proregenerative factors at 1, 3, and 7 days after cell administration in the liver, and analysis of the proliferating hepatocytes. (A): mRNA expression changes of factors related to fibrosis (matrix metalloproteinases [MMP] and tissue inhibitor of metalloprotease [TIMP]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of MMP‐8 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), MMP‐9 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and MMP‐13 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100) are upregulated, whereas in 50/50 group, mRNA levels of TIMP‐1 (p < .001; day 3, compared with control, p = .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and TIMP‐3 (p < .001; day 3, compared with control, p = .038; day 3, compared with MSC100, p = .029; day 3, compared with id‐BMM100) are downregulated. (B): mRNA expression changes of proregenerative factors (hepatocyte growth factor [HGF], vascular endothelial growth factor [VEGF], and oncostatin M [OSM]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of HGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .003; day 7, compared with id‐BMM100), VEGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p < .001; day 7, compared with id‐BMM100), and OSM (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .012; day 7, compared with id‐BMM100), are upregulated. (C): Analysis of the proliferating hepatocytes by PCNA staining at day 7 after cell administration. Data are presented as the means ± SD, n = 12 in each experiment, p = .003 (day 7) compared with day 1, p = .001 (day 7) compared with day 3. Scale bar: 100 μm.](https://figures.cochat.ai/paper-figures/65e06a554da7497e9526b5c665b093a6/mesenchymal-stem-cells-and-induced-bone-marrow-derived-macrophages-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Restorative (or pro-resolving) macrophages contribute to extracellular matrix degradation, myofibroblast inactivation, and tissue remodeling.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They secrete growth factors such as insulin-like growth factor-I (IGF-I) and hepatocyte growth factor (HGF), which support tissue repair and regeneration (1–4).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, intravital imaging with two-photon excitation microscopy, which is capable of distinguishing administered fluorescently labeled cells from dead cells, revealed a higher frequency of BMDM migration into the fibrotic liver, an augmented M2 cell subset, and increased phagocytic activity in the combined therapy group cohort compared to the BMDM monotherapy group.”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [85]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While many cell therapies, including MSC therapy, face a significant challenge of poor engraftment in the liver, EPCs and macrophages show much better engraftment outcomes [78, 85].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [85]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous preclinical studies have shown that macrophage therapy can reduce carbon tetrachloride–induced liver fibrosis (47–50) or promote the repair of acute liver injury repair (44, 51).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [49]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Stutchfield, B. M., Antoine, D. J., Mackinnon, A. C., Gow, D. J., Bain, C. C., Hawley, C. A., Hughes, M. J., Francis, B., Wojtacha, D., Man, T. Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.053 · Cited by 178
Self-citationRetractedMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citationStem Cell Therapies in Clinical Trials: Progress and Challenges
Trounson, A., & McDonald, C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.007 · Cited by 1,468
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.008 · Cited by 1,381
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0395 · Cited by 850
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Curry, M. P., O’Leary, J. G., Bzowej, N., Muir, A. J., Korenblat, K. M., Fenkel, J. M., Reddy, K. R., Lawitz, E., Flamm, S. L., Schiano, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512614 · Cited by 804
Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages
Kim, J., & Hematti, P. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.09.004 · Cited by 785
Boulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R. A., Seo, S. S., Spee, B., Van Rooijen, N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2667 · Cited by 747
Self-citation
Cited by
Items 101–161 of 161
Deng, Z., Zhou, J., Mu, X., Gu, J., Li, X., Shao, Q., Li, J., Yang, C., Han, G., Zhao, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737825 · Cited by 8
Motegi, S., Tsuchiya, A., Iwasawa, T., Sato, T., Kumagai, M., Natsui, K., Nojiri, S., Ogawa, M., Takeuchi, S., Sakai, Y., et al. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-021-00191-6 · Cited by 7
Self-citationHeparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model
Cheng, X., Jia, J., Zhang, T., Zhang, X., Vlodavsky, I., & Li, J. (2022) · Cells · doi:10.3390/cells11132035 · Cited by 7
Wang, T., Zhu, J., Gao, L., Wei, M., Zhang, D., Chen, L., Wu, H., Ma, J., Li, L., Zhang, N., et al. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12825 · Cited by 7
Fu, R., You, N., Li, R., Zhao, X., Li, Y., Li, X., & Jiang, W. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003635 · Cited by 7
Torabi, S., Zarrabi, M., Shekari, F., Poorkazem, H., Lotfinia, M., Bencina, S., Gramignoli, R., Hassan, M., Najimi, M., & Vosough, M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18507 · Cited by 7
Zhu, H., Zhuang, Y., Li, D., Dong, N., Ma, H., Liu, L., Shi, Q., & Ju, X. (2022) · Cell Transplantation · doi:10.1177/09636897221106996 · Cited by 7
Ishikawa, N., Watanabe, Y., Maeda, Y., Yoshida, T., Kimura, N., Abe, H., Sakamaki, A., Kamimura, H., Yokoo, T., Kamimura, K., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.01.017 · Cited by 6
Self-citationZhou, H., Wu, Y., Xue, J., & Yu, L.-S.-Y. (2025) · PubMed · doi:10.14670/hh-18-816 · Cited by 6
New perspectives in the treatment of liver cirrhosis: targeting macrophage regulatory mechanisms
Zheng, S., Li, S., Wang, Q., Zao, X., Li, X., Qi, W., Cheng, F., Yuexiao, G. E. N. G., Zhang, P., Shi, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07239-y · Cited by 6
Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity
Li, S., Wang, Y., Li, S., Zhu, Y., Du, Y., Zheng, X., & Wu, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04788-3 · Cited by 6
Strickland, J. D., & Copple, B. L. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.001 · Cited by 6
Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition
Igarashi, Y., Wada, H., Muto, M., Sone, R., Hasegawa, Y., & Seino, K.-I. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00364-7 · Cited by 5
Zeng, Y., Wu, Z., Chen, G., Liu, G., Zhang, B., Zhou, Y., Chen, M., Yao, R., & Shi, Y. (2024) · Stem Cells International · doi:10.1155/2024/4654912 · Cited by 5
Sant’Ana, A. N., Araújo, A. B., Gonçalves, F. D. C., & Paz, A. H. D. R. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1160 · Cited by 5
Attia, N., Khalifa, Y. H., Rostom, D. M., & Mashal, M. (2021) · Medical Research Archives · doi:10.18103/mra.v9i2.2318 · Cited by 5
Potential of Mesenchymal Stem Cells (MSCs) for Various Disease Therapy: Systematic Review
Aulia, A. F., Rismayani, D., Nopiyanti, T., Noli, Z. A., & Maliza, R. (2024) · JURNAL BIOLOGI TROPIS · doi:10.29303/jbt.v24i4.7006 · Cited by 4
Silva, B. M., & Bragança, J. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i2.99331 · Cited by 4
Immune cells in liver regeneration: Current evidence and potential clinical targets
Moore, H. F., Usmani, S., Froghi, S., Rashidi, H., Quaglia, A., Fuller, B. J., & Davidson, B. R. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2531820 · Cited by 4
Zhou, Q., Wang, J., Cheng, K., Mei, R., Heegsma, J., Moshage, H. J., Harmsen, M. C., Faber, K. N., & Sun, P. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04812-6 · Cited by 4
Liver regeneration: solved and problem issues
Plekhanov, A. N., & Искрович, Т. А. (2020) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia2020111101 · Cited by 4
Stem cells harvested from different sources ameliorate liver fibrosis: comparative study
Ali, I. S., Abdel-Wahab, N. D., & Nabil, A. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04707-6 · Cited by 3
Xu, S.-J., Ye, L., Wang, W., Chen, Y., Dong, J. W., Mao, X., & Li, S.-W. (2021) · Stem Cells International · doi:10.1155/2021/5513309 · Cited by 3
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
Liu, S., Ye, T., Wei, X., Qiu, F., Yan, X., Li, H., & Hu, X. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2542198 · Cited by 2
Small extracellular vesicles and liver diseases: From diagnosis to therapy
Tsuchiya, A., Natsui, K., Ishii, Y., Koseki, Y., Takeda, N., Tomiyoshi, K., Yamazaki, F., Yoshida, Y., & Terai, S. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1307 · Cited by 2
Self-citationZhang, Z., Sun, Y., Wang, H., Yang, Y., Dong, R., Xu, Y., Zhang, M., Lv, Q., Chen, X., & Liu, Y. (2023) · Toxin Reviews · doi:10.1080/15569543.2023.2191263 · Cited by 2
The anti-inflammatory effects of Sutherlandia Frutescens in a cell and animal model
Fortuin-Seedat, M. (2019) · Nelson Mandela University Research Repository · Cited by 2
Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages
Aquino, J. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792423 · Cited by 1
Li, R., Shu, Y., Yan, Y., Zhu, J., Cheng, Z., Zhang, J., Zhu, L., Qiao, Y., & Sun, Q. X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104903 · Cited by 1
Chen, Z., Yang, Y., Shi, X., Yang, R., Fang, W., Liang, G., Li, Y., Gao, J., Ma, L., Yang, J., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04774-9 · Cited by 1
Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration
五十嵐, 崇., Kimura, N., Abé, H., Yoshida, T., Watanabe, Y., Kamimura, H., Sakamaki, A., Yokoo, T., Kamimura, K., Tsuchiya, A., et al. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101065 · Cited by 1
Self-citationLiu, Y., Zhang, Y., Dou, W., Peng, W., Cheng, M., Zhou, Y., Shao, Q., & Wu, Y.-L. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10171-6 · Cited by 1
[Advances in the study of mesenchymal stem cells for end-stage liver disease].
Zheng, Y. Y., Zhu, S., Peng, L., & Gao, Z. L. (2021) · PubMed · doi:10.3760/cma.j.cn501113-20210610-00270 · Cited by 1
Liver regeneration: resolved and problem issues
Plekhanov, A. N., & Искрович, Т. А. (2021) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202102188 · Cited by 1
Wen, Y., Li, J., Mukama, O., Huang, R., Deng, S., & Li, Z. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.03.007 · Cited by 1
Vestnik Moskovskogo universiteta. Seria 16. Biologia
(2023) · Vestnik Moskovskogo universiteta Seria 16 Biologia · doi:10.55959/msu0137-0952-16 · Cited by 1
Heat treatment functionalizes hepatocyte-like cells derived from human embryonic stem cellsPreprint
Imamura, S., Yoshimoto, K., Terada, S., & Kamei, K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.10.983130
Thư, N. M., Trình, L. V., Thành, Đ. M., & Truong, N. H. (2021) · TẠP CHÍ KHOA HỌC ĐẠI HỌC MỞ THÀNH PHỐ HỒ CHÍ MINH - KỸ THUẬT VÀ CÔNG NGHỆ · doi:10.46223/hcmcoujs.tech.vi.16.1.1796.2021
Gong, Q., Jiang, Y., Pan, X., & You, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-329463/v1
CXCL12 mRNA expression as an independent marker of liver fi brogenesis in rats
Lebedeva, E. I., Babenka, A. S., & Shchastny, A. T. (2023) · Vestnik Moskovskogo universiteta Seria 16 Biologia · doi:10.55959/msu0137-0952-16-2022-77-4-248-257
CXCL12 mRNA Expression as an Independent Marker of Liver Fibrogenesis in Rats
Lebedeva, E. I., Babenka, A. S., & Shchastny, A. T. (2022) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392522040046
Sun, Z., Li, B., & Tian, X. (2024) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2024.3361
Jiang, Y. J., Huo, Q., Gao, J., Kou, B., Yusoff, N. M., Moses, E. J., & Lin, J. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x329341241018060516
Bone marrow mesenchymal stem cell transplantation for treatment of liver cirrhosis: Recent advances
Ruan, M.-F., Yin, Y.-H., Shao, X., & Qi, X. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i2.106
Comprehensive and translational pathobiology of COVID-19 based on cellular and molecular techniques
Samadani, A. A., Vahidi, S., Babaei, K., Norollahi, S. E., Delpasand, K., & Gharakhyli, E. A. (2025) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2025.e00497
Motegi, S., Tsuchiya, A., Iwasawa, T., Sato, T., Kumagai, M., Natsui, K., Nojiri, S., Ogawa, M., Takeuchi, S., Sakai, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19101885
Self-citationZhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., Zhao, X., Xiao, Z., Kuang, Y., Xu, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381988
Nojiri, S., Tsuchiya, A., Natsui, K., Takeuchi, S., Watanabe, T., Kojima, Y., Watanabe, Y., Kamimura, H., Ogawa, M., Motegi, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16682721
Self-citationTakeda, N., Tsuchiya, A., Mito, M., Natsui, K., Natusi, Y., Koseki, Y., Tomiyoshi, K., Yamazaki, F., Yoshida, Y., Abe, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24277214
Self-citationWen, Y., Amjad, N., Mukamab, O., Amissah, O. B., Xie, W., Zhou, P., Song, A., Wang, L., Li, J., Huang, R., et al. (2026) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00780-3
平川, 豊. (2022) · Institutional Repositories DataBase (IRDB)
インターフェロンγで刺激した間葉系幹細胞由来のエクソソームは肝線維化を効率的に改善する
Takauchi, S. (2021) · Institutional Repositories DataBase (IRDB)
Immunomodulatory Macrophages Enable E-MNC Therapy for Radiation-Induced Salivary Gland Hypofunction
本間遼 (2023) · Institutional Repositories DataBase (IRDB)
Amalina, N. D., Sitompul, F. N., Febri, R. R., Dewayanti, F. K., Rafidah, I., & Wargadipura, F. H. (2025) · International Journal of Cell and Biomedical Science · doi:10.59278/cbs.v4i12.81
Mesenchymal Stem Cells as Potential Therapeutics for Organ Fibrosis
Gazdic, M., Pavlovic, D., Ivosevic, Z., & Ljujić, B. (2026) · Future Pharmacology · doi:10.3390/futurepharmacol6020027
Tsuchiya, A., Watanabe, Y., Kimura, N., Abé, H., Setsu, T., Yokoo, T., Kamimura, H., Sakamaki, A., Saito, H., Tominaga, M., et al. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00421-9
Self-citationPensado‐López, A., Sánchez, A. R., & Torres, F. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_25
Introduction to metabolic memory
Gupta, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44591-0.00013-8
Metadata
- Authors
- Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., Yamagiwa, S., Forbes, S. J., Ishii, M., & Terai, S.
- Affiliations
- Niigata University (JP)
- b Medical Research Council Centre for Regenerative Medicine The University of Edinburgh, Edinburgh, United Kingdom
- MRC Centre for Regenerative Medicine (GB)
- The University of Osaka (JP)
- Corresponding author
- Tsuchiya, Atsunori
- Terai, Shuji
- ORCID
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-05
- Volume
- 8
- Issue
- 3
- Pages
- 271-284
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- PMC
- PMC6392382
- OpenAlex
- W2900422864
- Cited by
- 155
- References
- 29
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 13 · 2023: 30 · 2022: 26 · 2021: 27 · 2020: 18 · 2019: 13
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Stem Cells Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Agency for Medical Research and Development (17fk0210101h0001, 16bm0504003h0206)
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- mesenchymal stem cells, liver fibrosis, liver cirrhosis, M2 macrophage polarization, phagocytosis, hepatocyte regeneration, matrix metalloproteinases, hepatocyte growth factor, oncostatin M, vascular endothelial growth factor, carbon tetrachloride-induced liver injury, intravital imaging, macrophage migration, neutrophil infiltration
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Liver, Liver Cirrhosis, Liver Regeneration, Macrophages, Male, Mice, Inbred C57BL, Neutrophils, Hepatocytes, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.